世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
ライブアテンド日本脳炎ワクチンの世界市場成長率 2023-2029Global Live Attenuated Japanese Encephalitis Vaccine Market Growth 2023-2029 世界のLive Attenuated Japanese Encephalitis Vaccineの市場規模は、2022年の100万米ドルから2029年には100万米ドルになると予測されており、2023年から2029年までのCAGRは%であると予想されています。 ライブ... もっと見る
サマリー世界のLive Attenuated Japanese Encephalitis Vaccineの市場規模は、2022年の100万米ドルから2029年には100万米ドルになると予測されており、2023年から2029年までのCAGRは%であると予想されています。ライブアッテネート日本脳炎ワクチンの米国市場は、2023年から2029年までのCAGR %で、2022年の100万米ドルから2029年には100万米ドルまで増加すると予測されています。 中国市場は、2023年から2029年までのCAGRで、2022年の100万米ドルから2029年には100万米ドルに増加すると推定される。 ライブアテンド日本脳炎ワクチンのヨーロッパ市場は、2023年から2029年までのCAGRで、2022年の100万米ドルから2029年までに100万米ドルに増加すると推定されます。 世界の主要なライブアッテナイズド日本脳炎ワクチンプレーヤーは、ノバルティス、サノフィ、成都生物製品研究所、武漢生物製品研究所、蘭州生物製品研究所、北京天壇生物製品、バルネバ、バーラトバイオテック、チェンダバイオロジーなどをカバーしています。収益面では、世界の2大企業が2022年にほぼ％のシェアを占めています。 流行性日本脳炎（以下、JE）は、日本脳炎ウイルスによる中枢神経系の急性感染症で、脳実質の炎症が主な病変です。 LPI（エルピーアイ）の最新リサーチレポート「ライブアテンド日本脳炎ワクチン産業予測」は、2022年のライブアテンド日本脳炎ワクチンの世界総売上を過去の売上から検証し、2023年から2029年のライブアテンド日本脳炎ワクチン売上予測について地域や市場分野ごとに包括的に分析しています。また、地域別、市場分野別、サブセクター別に分類し、世界のライブアテンド日本脳炎ワクチン産業の詳細な分析（百万ドル単位）を提供します。 本インサイトレポートでは、世界のLive Attenuated Japanese Encephalitis Vaccineの状況を包括的に分析し、製品区分、会社設立、収益、市場シェア、最新開発、M&A活動に関する主要トレンドを明らかにしています。また、本レポートでは、加速する世界的な日本脳炎ワクチン市場において、これらの企業の独自のポジションをより深く理解するために、日本脳炎ワクチンのポートフォリオと能力、市場参入戦略、市場ポジション、地域的フットプリントに焦点を当てて、主要グローバル企業の戦略を分析しています。 本インサイトレポートでは、日本脳炎用生ワクチンの世界的な見通しを形成する主要な市場動向、推進要因、影響要因を評価し、タイプ別、用途別、地域別、市場規模別に予測を行い、新たな機会のポケットを明らかにします。何百ものボトムアップの定性的・定量的な市場インプットに基づく透明性の高い手法により、この調査予測は、世界の生きた日本脳炎ワクチンの現状と将来の軌道について非常にニュアンスのある見解を提供します。 本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別に、ライブアテンド日本脳炎ワクチン市場の包括的な概要、市場シェア、成長機会を紹介します。 市場のセグメンテーション タイプ別セグメンテーション 0.5ml 1ミリリットル 2.5ml 用途別セグメンテーション 病院 クリニック また、本レポートでは、地域別に市場を分割しています： 米州 アメリカ カナダ メキシコ ブラジル APAC 中国 日本 韓国 東南アジア インド オーストラリア 欧州 ドイツ フランス イギリス イタリア ロシア 中近東・アフリカ エジプト 南アフリカ イスラエル トルコ GCC諸国 以下の企業は、主要な専門家から収集した情報、企業のカバレッジ、製品ポートフォリオ、市場浸透度を分析した上で選定されています。 ノバルティス サノフィ 成都生物学的製剤研究所 武漢生物学的製剤研究所 蘭州生物学的製剤研究所 北京天壇生物学的製剤 バルネバ バーラト・バイオテック チェンダバイオロジー バイオセレクト・ピーティーイー・リミテッド 株式会社グロバックス 本レポートで取り上げる主な質問 日本脳炎ワクチンの世界市場の10年後の展望は？ 世界および地域別で、ライブアテンド日本脳炎ワクチン市場の成長を促進する要因は何か？ 市場別、地域別で最も速い成長を遂げる技術は何か？ 最終市場規模別にみたLive Attenuated Japanese Encephalitis Vaccineの市場機会はどのように変化しているか？ ライブアテンド日本脳炎ワクチンのタイプ別、用途別内訳は？ COVID-19とロシア・ウクライナ戦争の影響とは？ 目次1 Scope of the Report1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Live Attenuated Japanese Encephalitis Vaccine Annual Sales 2018-2029 2.1.2 World Current & Future Analysis for Live Attenuated Japanese Encephalitis Vaccine by Geographic Region, 2018, 2022 & 2029 2.1.3 World Current & Future Analysis for Live Attenuated Japanese Encephalitis Vaccine by Country/Region, 2018, 2022 & 2029 2.2 Live Attenuated Japanese Encephalitis Vaccine Segment by Type 2.2.1 0.5ml 2.2.2 1ml 2.2.3 2.5ml 2.3 Live Attenuated Japanese Encephalitis Vaccine Sales by Type 2.3.1 Global Live Attenuated Japanese Encephalitis Vaccine Sales Market Share by Type (2018-2023) 2.3.2 Global Live Attenuated Japanese Encephalitis Vaccine Revenue and Market Share by Type (2018-2023) 2.3.3 Global Live Attenuated Japanese Encephalitis Vaccine Sale Price by Type (2018-2023) 2.4 Live Attenuated Japanese Encephalitis Vaccine Segment by Application 2.4.1 Hospital 2.4.2 Clinic 2.5 Live Attenuated Japanese Encephalitis Vaccine Sales by Application 2.5.1 Global Live Attenuated Japanese Encephalitis Vaccine Sale Market Share by Application (2018-2023) 2.5.2 Global Live Attenuated Japanese Encephalitis Vaccine Revenue and Market Share by Application (2018-2023) 2.5.3 Global Live Attenuated Japanese Encephalitis Vaccine Sale Price by Application (2018-2023) 3 Global Live Attenuated Japanese Encephalitis Vaccine by Company 3.1 Global Live Attenuated Japanese Encephalitis Vaccine Breakdown Data by Company 3.1.1 Global Live Attenuated Japanese Encephalitis Vaccine Annual Sales by Company (2018-2023) 3.1.2 Global Live Attenuated Japanese Encephalitis Vaccine Sales Market Share by Company (2018-2023) 3.2 Global Live Attenuated Japanese Encephalitis Vaccine Annual Revenue by Company (2018-2023) 3.2.1 Global Live Attenuated Japanese Encephalitis Vaccine Revenue by Company (2018-2023) 3.2.2 Global Live Attenuated Japanese Encephalitis Vaccine Revenue Market Share by Company (2018-2023) 3.3 Global Live Attenuated Japanese Encephalitis Vaccine Sale Price by Company 3.4 Key Manufacturers Live Attenuated Japanese Encephalitis Vaccine Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Live Attenuated Japanese Encephalitis Vaccine Product Location Distribution 3.4.2 Players Live Attenuated Japanese Encephalitis Vaccine Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023) 3.6 New Products and Potential Entrants 3.7 Mergers & Acquisitions, Expansion 4 World Historic Review for Live Attenuated Japanese Encephalitis Vaccine by Geographic Region 4.1 World Historic Live Attenuated Japanese Encephalitis Vaccine Market Size by Geographic Region (2018-2023) 4.1.1 Global Live Attenuated Japanese Encephalitis Vaccine Annual Sales by Geographic Region (2018-2023) 4.1.2 Global Live Attenuated Japanese Encephalitis Vaccine Annual Revenue by Geographic Region (2018-2023) 4.2 World Historic Live Attenuated Japanese Encephalitis Vaccine Market Size by Country/Region (2018-2023) 4.2.1 Global Live Attenuated Japanese Encephalitis Vaccine Annual Sales by Country/Region (2018-2023) 4.2.2 Global Live Attenuated Japanese Encephalitis Vaccine Annual Revenue by Country/Region (2018-2023) 4.3 Americas Live Attenuated Japanese Encephalitis Vaccine Sales Growth 4.4 APAC Live Attenuated Japanese Encephalitis Vaccine Sales Growth 4.5 Europe Live Attenuated Japanese Encephalitis Vaccine Sales Growth 4.6 Middle East & Africa Live Attenuated Japanese Encephalitis Vaccine Sales Growth 5 Americas 5.1 Americas Live Attenuated Japanese Encephalitis Vaccine Sales by Country 5.1.1 Americas Live Attenuated Japanese Encephalitis Vaccine Sales by Country (2018-2023) 5.1.2 Americas Live Attenuated Japanese Encephalitis Vaccine Revenue by Country (2018-2023) 5.2 Americas Live Attenuated Japanese Encephalitis Vaccine Sales by Type 5.3 Americas Live Attenuated Japanese Encephalitis Vaccine Sales by Application 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Live Attenuated Japanese Encephalitis Vaccine Sales by Region 6.1.1 APAC Live Attenuated Japanese Encephalitis Vaccine Sales by Region (2018-2023) 6.1.2 APAC Live Attenuated Japanese Encephalitis Vaccine Revenue by Region (2018-2023) 6.2 APAC Live Attenuated Japanese Encephalitis Vaccine Sales by Type 6.3 APAC Live Attenuated Japanese Encephalitis Vaccine Sales by Application 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Live Attenuated Japanese Encephalitis Vaccine by Country 7.1.1 Europe Live Attenuated Japanese Encephalitis Vaccine Sales by Country (2018-2023) 7.1.2 Europe Live Attenuated Japanese Encephalitis Vaccine Revenue by Country (2018-2023) 7.2 Europe Live Attenuated Japanese Encephalitis Vaccine Sales by Type 7.3 Europe Live Attenuated Japanese Encephalitis Vaccine Sales by Application 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Live Attenuated Japanese Encephalitis Vaccine by Country 8.1.1 Middle East & Africa Live Attenuated Japanese Encephalitis Vaccine Sales by Country (2018-2023) 8.1.2 Middle East & Africa Live Attenuated Japanese Encephalitis Vaccine Revenue by Country (2018-2023) 8.2 Middle East & Africa Live Attenuated Japanese Encephalitis Vaccine Sales by Type 8.3 Middle East & Africa Live Attenuated Japanese Encephalitis Vaccine Sales by Application 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Live Attenuated Japanese Encephalitis Vaccine 10.3 Manufacturing Process Analysis of Live Attenuated Japanese Encephalitis Vaccine 10.4 Industry Chain Structure of Live Attenuated Japanese Encephalitis Vaccine 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Live Attenuated Japanese Encephalitis Vaccine Distributors 11.3 Live Attenuated Japanese Encephalitis Vaccine Customer 12 World Forecast Review for Live Attenuated Japanese Encephalitis Vaccine by Geographic Region 12.1 Global Live Attenuated Japanese Encephalitis Vaccine Market Size Forecast by Region 12.1.1 Global Live Attenuated Japanese Encephalitis Vaccine Forecast by Region (2024-2029) 12.1.2 Global Live Attenuated Japanese Encephalitis Vaccine Annual Revenue Forecast by Region (2024-2029) 12.2 Americas Forecast by Country 12.3 APAC Forecast by Region 12.4 Europe Forecast by Country 12.5 Middle East & Africa Forecast by Country 12.6 Global Live Attenuated Japanese Encephalitis Vaccine Forecast by Type 12.7 Global Live Attenuated Japanese Encephalitis Vaccine Forecast by Application 13 Key Players Analysis 13.1 Novartis 13.1.1 Novartis Company Information 13.1.2 Novartis Live Attenuated Japanese Encephalitis Vaccine Product Portfolios and Specifications 13.1.3 Novartis Live Attenuated Japanese Encephalitis Vaccine Sales, Revenue, Price and Gross Margin (2018-2023) 13.1.4 Novartis Main Business Overview 13.1.5 Novartis Latest Developments 13.2 Sanofi 13.2.1 Sanofi Company Information 13.2.2 Sanofi Live Attenuated Japanese Encephalitis Vaccine Product Portfolios and Specifications 13.2.3 Sanofi Live Attenuated Japanese Encephalitis Vaccine Sales, Revenue, Price and Gross Margin (2018-2023) 13.2.4 Sanofi Main Business Overview 13.2.5 Sanofi Latest Developments 13.3 Chengdu Institute of Biological Products 13.3.1 Chengdu Institute of Biological Products Company Information 13.3.2 Chengdu Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Product Portfolios and Specifications 13.3.3 Chengdu Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Sales, Revenue, Price and Gross Margin (2018-2023) 13.3.4 Chengdu Institute of Biological Products Main Business Overview 13.3.5 Chengdu Institute of Biological Products Latest Developments 13.4 Wuhan Institute of Biological Products 13.4.1 Wuhan Institute of Biological Products Company Information 13.4.2 Wuhan Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Product Portfolios and Specifications 13.4.3 Wuhan Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Sales, Revenue, Price and Gross Margin (2018-2023) 13.4.4 Wuhan Institute of Biological Products Main Business Overview 13.4.5 Wuhan Institute of Biological Products Latest Developments 13.5 Lanzhou Institute of Biological Products 13.5.1 Lanzhou Institute of Biological Products Company Information 13.5.2 Lanzhou Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Product Portfolios and Specifications 13.5.3 Lanzhou Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Sales, Revenue, Price and Gross Margin (2018-2023) 13.5.4 Lanzhou Institute of Biological Products Main Business Overview 13.5.5 Lanzhou Institute of Biological Products Latest Developments 13.6 Beijing Temple of Heaven Biological Products 13.6.1 Beijing Temple of Heaven Biological Products Company Information 13.6.2 Beijing Temple of Heaven Biological Products Live Attenuated Japanese Encephalitis Vaccine Product Portfolios and Specifications 13.6.3 Beijing Temple of Heaven Biological Products Live Attenuated Japanese Encephalitis Vaccine Sales, Revenue, Price and Gross Margin (2018-2023) 13.6.4 Beijing Temple of Heaven Biological Products Main Business Overview 13.6.5 Beijing Temple of Heaven Biological Products Latest Developments 13.7 Valneva 13.7.1 Valneva Company Information 13.7.2 Valneva Live Attenuated Japanese Encephalitis Vaccine Product Portfolios and Specifications 13.7.3 Valneva Live Attenuated Japanese Encephalitis Vaccine Sales, Revenue, Price and Gross Margin (2018-2023) 13.7.4 Valneva Main Business Overview 13.7.5 Valneva Latest Developments 13.8 Bharat Biotech 13.8.1 Bharat Biotech Company Information 13.8.2 Bharat Biotech Live Attenuated Japanese Encephalitis Vaccine Product Portfolios and Specifications 13.8.3 Bharat Biotech Live Attenuated Japanese Encephalitis Vaccine Sales, Revenue, Price and Gross Margin (2018-2023) 13.8.4 Bharat Biotech Main Business Overview 13.8.5 Bharat Biotech Latest Developments 13.9 Cheng Da Biology 13.9.1 Cheng Da Biology Company Information 13.9.2 Cheng Da Biology Live Attenuated Japanese Encephalitis Vaccine Product Portfolios and Specifications 13.9.3 Cheng Da Biology Live Attenuated Japanese Encephalitis Vaccine Sales, Revenue, Price and Gross Margin (2018-2023) 13.9.4 Cheng Da Biology Main Business Overview 13.9.5 Cheng Da Biology Latest Developments 13.10 Biocelect Pty Ltd 13.10.1 Biocelect Pty Ltd Company Information 13.10.2 Biocelect Pty Ltd Live Attenuated Japanese Encephalitis Vaccine Product Portfolios and Specifications 13.10.3 Biocelect Pty Ltd Live Attenuated Japanese Encephalitis Vaccine Sales, Revenue, Price and Gross Margin (2018-2023) 13.10.4 Biocelect Pty Ltd Main Business Overview 13.10.5 Biocelect Pty Ltd Latest Developments 13.11 Glovax Co., Ltd. 13.11.1 Glovax Co., Ltd. Company Information 13.11.2 Glovax Co., Ltd. Live Attenuated Japanese Encephalitis Vaccine Product Portfolios and Specifications 13.11.3 Glovax Co., Ltd. Live Attenuated Japanese Encephalitis Vaccine Sales, Revenue, Price and Gross Margin (2018-2023) 13.11.4 Glovax Co., Ltd. Main Business Overview 13.11.5 Glovax Co., Ltd. Latest Developments 14 Research Findings and Conclusion 図表リストList of TablesTable 1. Live Attenuated Japanese Encephalitis Vaccine Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions) Table 2. Live Attenuated Japanese Encephalitis Vaccine Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions) Table 3. Major Players of 0.5ml Table 4. Major Players of 1ml Table 5. Major Players of 2.5ml Table 6. Global Live Attenuated Japanese Encephalitis Vaccine Sales by Type (2018-2023) & (K Units) Table 7. Global Live Attenuated Japanese Encephalitis Vaccine Sales Market Share by Type (2018-2023) Table 8. Global Live Attenuated Japanese Encephalitis Vaccine Revenue by Type (2018-2023) & ($ million) Table 9. Global Live Attenuated Japanese Encephalitis Vaccine Revenue Market Share by Type (2018-2023) Table 10. Global Live Attenuated Japanese Encephalitis Vaccine Sale Price by Type (2018-2023) & (US$/Unit) Table 11. Global Live Attenuated Japanese Encephalitis Vaccine Sales by Application (2018-2023) & (K Units) Table 12. Global Live Attenuated Japanese Encephalitis Vaccine Sales Market Share by Application (2018-2023) Table 13. Global Live Attenuated Japanese Encephalitis Vaccine Revenue by Application (2018-2023) Table 14. Global Live Attenuated Japanese Encephalitis Vaccine Revenue Market Share by Application (2018-2023) Table 15. Global Live Attenuated Japanese Encephalitis Vaccine Sale Price by Application (2018-2023) & (US$/Unit) Table 16. Global Live Attenuated Japanese Encephalitis Vaccine Sales by Company (2018-2023) & (K Units) Table 17. Global Live Attenuated Japanese Encephalitis Vaccine Sales Market Share by Company (2018-2023) Table 18. Global Live Attenuated Japanese Encephalitis Vaccine Revenue by Company (2018-2023) ($ Millions) Table 19. Global Live Attenuated Japanese Encephalitis Vaccine Revenue Market Share by Company (2018-2023) Table 20. Global Live Attenuated Japanese Encephalitis Vaccine Sale Price by Company (2018-2023) & (US$/Unit) Table 21. Key Manufacturers Live Attenuated Japanese Encephalitis Vaccine Producing Area Distribution and Sales Area Table 22. Players Live Attenuated Japanese Encephalitis Vaccine Products Offered Table 23. Live Attenuated Japanese Encephalitis Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2018-2023) Table 24. New Products and Potential Entrants Table 25. Mergers & Acquisitions, Expansion Table 26. Global Live Attenuated Japanese Encephalitis Vaccine Sales by Geographic Region (2018-2023) & (K Units) Table 27. Global Live Attenuated Japanese Encephalitis Vaccine Sales Market Share Geographic Region (2018-2023) Table 28. Global Live Attenuated Japanese Encephalitis Vaccine Revenue by Geographic Region (2018-2023) & ($ millions) Table 29. Global Live Attenuated Japanese Encephalitis Vaccine Revenue Market Share by Geographic Region (2018-2023) Table 30. Global Live Attenuated Japanese Encephalitis Vaccine Sales by Country/Region (2018-2023) & (K Units) Table 31. Global Live Attenuated Japanese Encephalitis Vaccine Sales Market Share by Country/Region (2018-2023) Table 32. Global Live Attenuated Japanese Encephalitis Vaccine Revenue by Country/Region (2018-2023) & ($ millions) Table 33. Global Live Attenuated Japanese Encephalitis Vaccine Revenue Market Share by Country/Region (2018-2023) Table 34. Americas Live Attenuated Japanese Encephalitis Vaccine Sales by Country (2018-2023) & (K Units) Table 35. Americas Live Attenuated Japanese Encephalitis Vaccine Sales Market Share by Country (2018-2023) Table 36. Americas Live Attenuated Japanese Encephalitis Vaccine Revenue by Country (2018-2023) & ($ Millions) Table 37. Americas Live Attenuated Japanese Encephalitis Vaccine Revenue Market Share by Country (2018-2023) Table 38. Americas Live Attenuated Japanese Encephalitis Vaccine Sales by Type (2018-2023) & (K Units) Table 39. Americas Live Attenuated Japanese Encephalitis Vaccine Sales by Application (2018-2023) & (K Units) Table 40. APAC Live Attenuated Japanese Encephalitis Vaccine Sales by Region (2018-2023) & (K Units) Table 41. APAC Live Attenuated Japanese Encephalitis Vaccine Sales Market Share by Region (2018-2023) Table 42. APAC Live Attenuated Japanese Encephalitis Vaccine Revenue by Region (2018-2023) & ($ Millions) Table 43. APAC Live Attenuated Japanese Encephalitis Vaccine Revenue Market Share by Region (2018-2023) Table 44. APAC Live Attenuated Japanese Encephalitis Vaccine Sales by Type (2018-2023) & (K Units) Table 45. APAC Live Attenuated Japanese Encephalitis Vaccine Sales by Application (2018-2023) & (K Units) Table 46. Europe Live Attenuated Japanese Encephalitis Vaccine Sales by Country (2018-2023) & (K Units) Table 47. Europe Live Attenuated Japanese Encephalitis Vaccine Sales Market Share by Country (2018-2023) Table 48. Europe Live Attenuated Japanese Encephalitis Vaccine Revenue by Country (2018-2023) & ($ Millions) Table 49. Europe Live Attenuated Japanese Encephalitis Vaccine Revenue Market Share by Country (2018-2023) Table 50. Europe Live Attenuated Japanese Encephalitis Vaccine Sales by Type (2018-2023) & (K Units) Table 51. Europe Live Attenuated Japanese Encephalitis Vaccine Sales by Application (2018-2023) & (K Units) Table 52. Middle East & Africa Live Attenuated Japanese Encephalitis Vaccine Sales by Country (2018-2023) & (K Units) Table 53. Middle East & Africa Live Attenuated Japanese Encephalitis Vaccine Sales Market Share by Country (2018-2023) Table 54. Middle East & Africa Live Attenuated Japanese Encephalitis Vaccine Revenue by Country (2018-2023) & ($ Millions) Table 55. Middle East & Africa Live Attenuated Japanese Encephalitis Vaccine Revenue Market Share by Country (2018-2023) Table 56. Middle East & Africa Live Attenuated Japanese Encephalitis Vaccine Sales by Type (2018-2023) & (K Units) Table 57. Middle East & Africa Live Attenuated Japanese Encephalitis Vaccine Sales by Application (2018-2023) & (K Units) Table 58. Key Market Drivers & Growth Opportunities of Live Attenuated Japanese Encephalitis Vaccine Table 59. Key Market Challenges & Risks of Live Attenuated Japanese Encephalitis Vaccine Table 60. Key Industry Trends of Live Attenuated Japanese Encephalitis Vaccine Table 61. Live Attenuated Japanese Encephalitis Vaccine Raw Material Table 62. Key Suppliers of Raw Materials Table 63. Live Attenuated Japanese Encephalitis Vaccine Distributors List Table 64. Live Attenuated Japanese Encephalitis Vaccine Customer List Table 65. Global Live Attenuated Japanese Encephalitis Vaccine Sales Forecast by Region (2024-2029) & (K Units) Table 66. Global Live Attenuated Japanese Encephalitis Vaccine Revenue Forecast by Region (2024-2029) & ($ millions) Table 67. Americas Live Attenuated Japanese Encephalitis Vaccine Sales Forecast by Country (2024-2029) & (K Units) Table 68. Americas Live Attenuated Japanese Encephalitis Vaccine Revenue Forecast by Country (2024-2029) & ($ millions) Table 69. APAC Live Attenuated Japanese Encephalitis Vaccine Sales Forecast by Region (2024-2029) & (K Units) Table 70. APAC Live Attenuated Japanese Encephalitis Vaccine Revenue Forecast by Region (2024-2029) & ($ millions) Table 71. Europe Live Attenuated Japanese Encephalitis Vaccine Sales Forecast by Country (2024-2029) & (K Units) Table 72. Europe Live Attenuated Japanese Encephalitis Vaccine Revenue Forecast by Country (2024-2029) & ($ millions) Table 73. Middle East & Africa Live Attenuated Japanese Encephalitis Vaccine Sales Forecast by Country (2024-2029) & (K Units) Table 74. Middle East & Africa Live Attenuated Japanese Encephalitis Vaccine Revenue Forecast by Country (2024-2029) & ($ millions) Table 75. Global Live Attenuated Japanese Encephalitis Vaccine Sales Forecast by Type (2024-2029) & (K Units) Table 76. Global Live Attenuated Japanese Encephalitis Vaccine Revenue Forecast by Type (2024-2029) & ($ Millions) Table 77. Global Live Attenuated Japanese Encephalitis Vaccine Sales Forecast by Application (2024-2029) & (K Units) Table 78. Global Live Attenuated Japanese Encephalitis Vaccine Revenue Forecast by Application (2024-2029) & ($ Millions) Table 79. Novartis Basic Information, Live Attenuated Japanese Encephalitis Vaccine Manufacturing Base, Sales Area and Its Competitors Table 80. Novartis Live Attenuated Japanese Encephalitis Vaccine Product Portfolios and Specifications Table 81. Novartis Live Attenuated Japanese Encephalitis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 82. Novartis Main Business Table 83. Novartis Latest Developments Table 84. Sanofi Basic Information, Live Attenuated Japanese Encephalitis Vaccine Manufacturing Base, Sales Area and Its Competitors Table 85. Sanofi Live Attenuated Japanese Encephalitis Vaccine Product Portfolios and Specifications Table 86. Sanofi Live Attenuated Japanese Encephalitis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 87. Sanofi Main Business Table 88. Sanofi Latest Developments Table 89. Chengdu Institute of Biological Products Basic Information, Live Attenuated Japanese Encephalitis Vaccine Manufacturing Base, Sales Area and Its Competitors Table 90. Chengdu Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Product Portfolios and Specifications Table 91. Chengdu Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 92. Chengdu Institute of Biological Products Main Business Table 93. Chengdu Institute of Biological Products Latest Developments Table 94. Wuhan Institute of Biological Products Basic Information, Live Attenuated Japanese Encephalitis Vaccine Manufacturing Base, Sales Area and Its Competitors Table 95. Wuhan Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Product Portfolios and Specifications Table 96. Wuhan Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 97. Wuhan Institute of Biological Products Main Business Table 98. Wuhan Institute of Biological Products Latest Developments Table 99. Lanzhou Institute of Biological Products Basic Information, Live Attenuated Japanese Encephalitis Vaccine Manufacturing Base, Sales Area and Its Competitors Table 100. Lanzhou Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Product Portfolios and Specifications Table 101. Lanzhou Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 102. Lanzhou Institute of Biological Products Main Business Table 103. Lanzhou Institute of Biological Products Latest Developments Table 104. Beijing Temple of Heaven Biological Products Basic Information, Live Attenuated Japanese Encephalitis Vaccine Manufacturing Base, Sales Area and Its Competitors Table 105. Beijing Temple of Heaven Biological Products Live Attenuated Japanese Encephalitis Vaccine Product Portfolios and Specifications Table 106. Beijing Temple of Heaven Biological Products Live Attenuated Japanese Encephalitis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 107. Beijing Temple of Heaven Biological Products Main Business Table 108. Beijing Temple of Heaven Biological Products Latest Developments Table 109. Valneva Basic Information, Live Attenuated Japanese Encephalitis Vaccine Manufacturing Base, Sales Area and Its Competitors Table 110. Valneva Live Attenuated Japanese Encephalitis Vaccine Product Portfolios and Specifications Table 111. Valneva Live Attenuated Japanese Encephalitis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 112. Valneva Main Business Table 113. Valneva Latest Developments Table 114. Bharat Biotech Basic Information, Live Attenuated Japanese Encephalitis Vaccine Manufacturing Base, Sales Area and Its Competitors Table 115. Bharat Biotech Live Attenuated Japanese Encephalitis Vaccine Product Portfolios and Specifications Table 116. Bharat Biotech Live Attenuated Japanese Encephalitis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 117. Bharat Biotech Main Business Table 118. Bharat Biotech Latest Developments Table 119. Cheng Da Biology Basic Information, Live Attenuated Japanese Encephalitis Vaccine Manufacturing Base, Sales Area and Its Competitors Table 120. Cheng Da Biology Live Attenuated Japanese Encephalitis Vaccine Product Portfolios and Specifications Table 121. Cheng Da Biology Live Attenuated Japanese Encephalitis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 122. Cheng Da Biology Main Business Table 123. Cheng Da Biology Latest Developments Table 124. Biocelect Pty Ltd Basic Information, Live Attenuated Japanese Encephalitis Vaccine Manufacturing Base, Sales Area and Its Competitors Table 125. Biocelect Pty Ltd Live Attenuated Japanese Encephalitis Vaccine Product Portfolios and Specifications Table 126. Biocelect Pty Ltd Live Attenuated Japanese Encephalitis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 127. Biocelect Pty Ltd Main Business Table 128. Biocelect Pty Ltd Latest Developments Table 129. Glovax Co., Ltd. Basic Information, Live Attenuated Japanese Encephalitis Vaccine Manufacturing Base, Sales Area and Its Competitors Table 130. Glovax Co., Ltd. Live Attenuated Japanese Encephalitis Vaccine Product Portfolios and Specifications Table 131. Glovax Co., Ltd. Live Attenuated Japanese Encephalitis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 132. Glovax Co., Ltd. Main Business Table 133. Glovax Co., Ltd. Latest Developments List of Figures Figure 1. Picture of Live Attenuated Japanese Encephalitis Vaccine Figure 2. Live Attenuated Japanese Encephalitis Vaccine Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Live Attenuated Japanese Encephalitis Vaccine Sales Growth Rate 2018-2029 (K Units) Figure 7. Global Live Attenuated Japanese Encephalitis Vaccine Revenue Growth Rate 2018-2029 ($ Millions) Figure 8. Live Attenuated Japanese Encephalitis Vaccine Sales by Region (2018, 2022 & 2029) & ($ Millions) Figure 9. Product Picture of 0.5ml Figure 10. Product Picture of 1ml Figure 11. Product Picture of 2.5ml Figure 12. Global Live Attenuated Japanese Encephalitis Vaccine Sales Market Share by Type in 2022 Figure 13. Global Live Attenuated Japanese Encephalitis Vaccine Revenue Market Share by Type (2018-2023) Figure 14. Live Attenuated Japanese Encephalitis Vaccine Consumed in Hospital Figure 15. Global Live Attenuated Japanese Encephalitis Vaccine Market: Hospital (2018-2023) & (K Units) Figure 16. Live Attenuated Japanese Encephalitis Vaccine Consumed in Clinic Figure 17. Global Live Attenuated Japanese Encephalitis Vaccine Market: Clinic (2018-2023) & (K Units) Figure 18. Global Live Attenuated Japanese Encephalitis Vaccine Sales Market Share by Application (2022) Figure 19. Global Live Attenuated Japanese Encephalitis Vaccine Revenue Market Share by Application in 2022 Figure 20. Live Attenuated Japanese Encephalitis Vaccine Sales Market by Company in 2022 (K Units) Figure 21. Global Live Attenuated Japanese Encephalitis Vaccine Sales Market Share by Company in 2022 Figure 22. Live Attenuated Japanese Encephalitis Vaccine Revenue Market by Company in 2022 ($ Million) Figure 23. Global Live Attenuated Japanese Encephalitis Vaccine Revenue Market Share by Company in 2022 Figure 24. Global Live Attenuated Japanese Encephalitis Vaccine Sales Market Share by Geographic Region (2018-2023) Figure 25. Global Live Attenuated Japanese Encephalitis Vaccine Revenue Market Share by Geographic Region in 2022 Figure 26. Americas Live Attenuated Japanese Encephalitis Vaccine Sales 2018-2023 (K Units) Figure 27. Americas Live Attenuated Japanese Encephalitis Vaccine Revenue 2018-2023 ($ Millions) Figure 28. APAC Live Attenuated Japanese Encephalitis Vaccine Sales 2018-2023 (K Units) Figure 29. APAC Live Attenuated Japanese Encephalitis Vaccine Revenue 2018-2023 ($ Millions) Figure 30. Europe Live Attenuated Japanese Encephalitis Vaccine Sales 2018-2023 (K Units) Figure 31. Europe Live Attenuated Japanese Encephalitis Vaccine Revenue 2018-2023 ($ Millions) Figure 32. Middle East & Africa Live Attenuated Japanese Encephalitis Vaccine Sales 2018-2023 (K Units) Figure 33. Middle East & Africa Live Attenuated Japanese Encephalitis Vaccine Revenue 2018-2023 ($ Millions) Figure 34. Americas Live Attenuated Japanese Encephalitis Vaccine Sales Market Share by Country in 2022 Figure 35. Americas Live Attenuated Japanese Encephalitis Vaccine Revenue Market Share by Country in 2022 Figure 36. Americas Live Attenuated Japanese Encephalitis Vaccine Sales Market Share by Type (2018-2023) Figure 37. Americas Live Attenuated Japanese Encephalitis Vaccine Sales Market Share by Application (2018-2023) Figure 38. United States Live Attenuated Japanese Encephalitis Vaccine Revenue Growth 2018-2023 ($ Millions) Figure 39. Canada Live Attenuated Japanese Encephalitis Vaccine Revenue Growth 2018-2023 ($ Millions) Figure 40. Mexico Live Attenuated Japanese Encephalitis Vaccine Revenue Growth 2018-2023 ($ Millions) Figure 41. Brazil Live Attenuated Japanese Encephalitis Vaccine Revenue Growth 2018-2023 ($ Millions) Figure 42. APAC Live Attenuated Japanese Encephalitis Vaccine Sales Market Share by Region in 2022 Figure 43. APAC Live Attenuated Japanese Encephalitis Vaccine Revenue Market Share by Regions in 2022 Figure 44. APAC Live Attenuated Japanese Encephalitis Vaccine Sales Market Share by Type (2018-2023) Figure 45. APAC Live Attenuated Japanese Encephalitis Vaccine Sales Market Share by Application (2018-2023) Figure 46. China Live Attenuated Japanese Encephalitis Vaccine Revenue Growth 2018-2023 ($ Millions) Figure 47. Japan Live Attenuated Japanese Encephalitis Vaccine Revenue Growth 2018-2023 ($ Millions) Figure 48. South Korea Live Attenuated Japanese Encephalitis Vaccine Revenue Growth 2018-2023 ($ Millions) Figure 49. Southeast Asia Live Attenuated Japanese Encephalitis Vaccine Revenue Growth 2018-2023 ($ Millions) Figure 50. India Live Attenuated Japanese Encephalitis Vaccine Revenue Growth 2018-2023 ($ Millions) Figure 51. Australia Live Attenuated Japanese Encephalitis Vaccine Revenue Growth 2018-2023 ($ Millions) Figure 52. China Taiwan Live Attenuated Japanese Encephalitis Vaccine Revenue Growth 2018-2023 ($ Millions) Figure 53. Europe Live Attenuated Japanese Encephalitis Vaccine Sales Market Share by Country in 2022 Figure 54. Europe Live Attenuated Japanese Encephalitis Vaccine Revenue Market Share by Country in 2022 Figure 55. Europe Live Attenuated Japanese Encephalitis Vaccine Sales Market Share by Type (2018-2023) Figure 56. Europe Live Attenuated Japanese Encephalitis Vaccine Sales Market Share by Application (2018-2023) Figure 57. Germany Live Attenuated Japanese Encephalitis Vaccine Revenue Growth 2018-2023 ($ Millions) Figure 58. France Live Attenuated Japanese Encephalitis Vaccine Revenue Growth 2018-2023 ($ Millions) Figure 59. UK Live Attenuated Japanese Encephalitis Vaccine Revenue Growth 2018-2023 ($ Millions) Figure 60. Italy Live Attenuated Japanese Encephalitis Vaccine Revenue Growth 2018-2023 ($ Millions) Figure 61. Russia Live Attenuated Japanese Encephalitis Vaccine Revenue Growth 2018-2023 ($ Millions) Figure 62. Middle East & Africa Live Attenuated Japanese Encephalitis Vaccine Sales Market Share by Country in 2022 Figure 63. Middle East & Africa Live Attenuated Japanese Encephalitis Vaccine Revenue Market Share by Country in 2022 Figure 64. Middle East & Africa Live Attenuated Japanese Encephalitis Vaccine Sales Market Share by Type (2018-2023) Figure 65. Middle East & Africa Live Attenuated Japanese Encephalitis Vaccine Sales Market Share by Application (2018-2023) Figure 66. Egypt Live Attenuated Japanese Encephalitis Vaccine Revenue Growth 2018-2023 ($ Millions) Figure 67. South Africa Live Attenuated Japanese Encephalitis Vaccine Revenue Growth 2018-2023 ($ Millions) Figure 68. Israel Live Attenuated Japanese Encephalitis Vaccine Revenue Growth 2018-2023 ($ Millions) Figure 69. Turkey Live Attenuated Japanese Encephalitis Vaccine Revenue Growth 2018-2023 ($ Millions) Figure 70. GCC Country Live Attenuated Japanese Encephalitis Vaccine Revenue Growth 2018-2023 ($ Millions) Figure 71. Manufacturing Cost Structure Analysis of Live Attenuated Japanese Encephalitis Vaccine in 2022 Figure 72. Manufacturing Process Analysis of Live Attenuated Japanese Encephalitis Vaccine Figure 73. Industry Chain Structure of Live Attenuated Japanese Encephalitis Vaccine Figure 74. Channels of Distribution Figure 75. Global Live Attenuated Japanese Encephalitis Vaccine Sales Market Forecast by Region (2024-2029) Figure 76. Global Live Attenuated Japanese Encephalitis Vaccine Revenue Market Share Forecast by Region (2024-2029) Figure 77. Global Live Attenuated Japanese Encephalitis Vaccine Sales Market Share Forecast by Type (2024-2029) Figure 78. Global Live Attenuated Japanese Encephalitis Vaccine Revenue Market Share Forecast by Type (2024-2029) Figure 79. Global Live Attenuated Japanese Encephalitis Vaccine Sales Market Share Forecast by Application (2024-2029) Figure 80. Global Live Attenuated Japanese Encephalitis Vaccine Revenue Market Share Forecast by Application (2024-2029)
SummaryThe global Live Attenuated Japanese Encephalitis Vaccine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029. Table of Contents1 Scope of the Report1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Live Attenuated Japanese Encephalitis Vaccine Annual Sales 2018-2029 2.1.2 World Current & Future Analysis for Live Attenuated Japanese Encephalitis Vaccine by Geographic Region, 2018, 2022 & 2029 2.1.3 World Current & Future Analysis for Live Attenuated Japanese Encephalitis Vaccine by Country/Region, 2018, 2022 & 2029 2.2 Live Attenuated Japanese Encephalitis Vaccine Segment by Type 2.2.1 0.5ml 2.2.2 1ml 2.2.3 2.5ml 2.3 Live Attenuated Japanese Encephalitis Vaccine Sales by Type 2.3.1 Global Live Attenuated Japanese Encephalitis Vaccine Sales Market Share by Type (2018-2023) 2.3.2 Global Live Attenuated Japanese Encephalitis Vaccine Revenue and Market Share by Type (2018-2023) 2.3.3 Global Live Attenuated Japanese Encephalitis Vaccine Sale Price by Type (2018-2023) 2.4 Live Attenuated Japanese Encephalitis Vaccine Segment by Application 2.4.1 Hospital 2.4.2 Clinic 2.5 Live Attenuated Japanese Encephalitis Vaccine Sales by Application 2.5.1 Global Live Attenuated Japanese Encephalitis Vaccine Sale Market Share by Application (2018-2023) 2.5.2 Global Live Attenuated Japanese Encephalitis Vaccine Revenue and Market Share by Application (2018-2023) 2.5.3 Global Live Attenuated Japanese Encephalitis Vaccine Sale Price by Application (2018-2023) 3 Global Live Attenuated Japanese Encephalitis Vaccine by Company 3.1 Global Live Attenuated Japanese Encephalitis Vaccine Breakdown Data by Company 3.1.1 Global Live Attenuated Japanese Encephalitis Vaccine Annual Sales by Company (2018-2023) 3.1.2 Global Live Attenuated Japanese Encephalitis Vaccine Sales Market Share by Company (2018-2023) 3.2 Global Live Attenuated Japanese Encephalitis Vaccine Annual Revenue by Company (2018-2023) 3.2.1 Global Live Attenuated Japanese Encephalitis Vaccine Revenue by Company (2018-2023) 3.2.2 Global Live Attenuated Japanese Encephalitis Vaccine Revenue Market Share by Company (2018-2023) 3.3 Global Live Attenuated Japanese Encephalitis Vaccine Sale Price by Company 3.4 Key Manufacturers Live Attenuated Japanese Encephalitis Vaccine Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Live Attenuated Japanese Encephalitis Vaccine Product Location Distribution 3.4.2 Players Live Attenuated Japanese Encephalitis Vaccine Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023) 3.6 New Products and Potential Entrants 3.7 Mergers & Acquisitions, Expansion 4 World Historic Review for Live Attenuated Japanese Encephalitis Vaccine by Geographic Region 4.1 World Historic Live Attenuated Japanese Encephalitis Vaccine Market Size by Geographic Region (2018-2023) 4.1.1 Global Live Attenuated Japanese Encephalitis Vaccine Annual Sales by Geographic Region (2018-2023) 4.1.2 Global Live Attenuated Japanese Encephalitis Vaccine Annual Revenue by Geographic Region (2018-2023) 4.2 World Historic Live Attenuated Japanese Encephalitis Vaccine Market Size by Country/Region (2018-2023) 4.2.1 Global Live Attenuated Japanese Encephalitis Vaccine Annual Sales by Country/Region (2018-2023) 4.2.2 Global Live Attenuated Japanese Encephalitis Vaccine Annual Revenue by Country/Region (2018-2023) 4.3 Americas Live Attenuated Japanese Encephalitis Vaccine Sales Growth 4.4 APAC Live Attenuated Japanese Encephalitis Vaccine Sales Growth 4.5 Europe Live Attenuated Japanese Encephalitis Vaccine Sales Growth 4.6 Middle East & Africa Live Attenuated Japanese Encephalitis Vaccine Sales Growth 5 Americas 5.1 Americas Live Attenuated Japanese Encephalitis Vaccine Sales by Country 5.1.1 Americas Live Attenuated Japanese Encephalitis Vaccine Sales by Country (2018-2023) 5.1.2 Americas Live Attenuated Japanese Encephalitis Vaccine Revenue by Country (2018-2023) 5.2 Americas Live Attenuated Japanese Encephalitis Vaccine Sales by Type 5.3 Americas Live Attenuated Japanese Encephalitis Vaccine Sales by Application 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Live Attenuated Japanese Encephalitis Vaccine Sales by Region 6.1.1 APAC Live Attenuated Japanese Encephalitis Vaccine Sales by Region (2018-2023) 6.1.2 APAC Live Attenuated Japanese Encephalitis Vaccine Revenue by Region (2018-2023) 6.2 APAC Live Attenuated Japanese Encephalitis Vaccine Sales by Type 6.3 APAC Live Attenuated Japanese Encephalitis Vaccine Sales by Application 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Live Attenuated Japanese Encephalitis Vaccine by Country 7.1.1 Europe Live Attenuated Japanese Encephalitis Vaccine Sales by Country (2018-2023) 7.1.2 Europe Live Attenuated Japanese Encephalitis Vaccine Revenue by Country (2018-2023) 7.2 Europe Live Attenuated Japanese Encephalitis Vaccine Sales by Type 7.3 Europe Live Attenuated Japanese Encephalitis Vaccine Sales by Application 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Live Attenuated Japanese Encephalitis Vaccine by Country 8.1.1 Middle East & Africa Live Attenuated Japanese Encephalitis Vaccine Sales by Country (2018-2023) 8.1.2 Middle East & Africa Live Attenuated Japanese Encephalitis Vaccine Revenue by Country (2018-2023) 8.2 Middle East & Africa Live Attenuated Japanese Encephalitis Vaccine Sales by Type 8.3 Middle East & Africa Live Attenuated Japanese Encephalitis Vaccine Sales by Application 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Live Attenuated Japanese Encephalitis Vaccine 10.3 Manufacturing Process Analysis of Live Attenuated Japanese Encephalitis Vaccine 10.4 Industry Chain Structure of Live Attenuated Japanese Encephalitis Vaccine 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Live Attenuated Japanese Encephalitis Vaccine Distributors 11.3 Live Attenuated Japanese Encephalitis Vaccine Customer 12 World Forecast Review for Live Attenuated Japanese Encephalitis Vaccine by Geographic Region 12.1 Global Live Attenuated Japanese Encephalitis Vaccine Market Size Forecast by Region 12.1.1 Global Live Attenuated Japanese Encephalitis Vaccine Forecast by Region (2024-2029) 12.1.2 Global Live Attenuated Japanese Encephalitis Vaccine Annual Revenue Forecast by Region (2024-2029) 12.2 Americas Forecast by Country 12.3 APAC Forecast by Region 12.4 Europe Forecast by Country 12.5 Middle East & Africa Forecast by Country 12.6 Global Live Attenuated Japanese Encephalitis Vaccine Forecast by Type 12.7 Global Live Attenuated Japanese Encephalitis Vaccine Forecast by Application 13 Key Players Analysis 13.1 Novartis 13.1.1 Novartis Company Information 13.1.2 Novartis Live Attenuated Japanese Encephalitis Vaccine Product Portfolios and Specifications 13.1.3 Novartis Live Attenuated Japanese Encephalitis Vaccine Sales, Revenue, Price and Gross Margin (2018-2023) 13.1.4 Novartis Main Business Overview 13.1.5 Novartis Latest Developments 13.2 Sanofi 13.2.1 Sanofi Company Information 13.2.2 Sanofi Live Attenuated Japanese Encephalitis Vaccine Product Portfolios and Specifications 13.2.3 Sanofi Live Attenuated Japanese Encephalitis Vaccine Sales, Revenue, Price and Gross Margin (2018-2023) 13.2.4 Sanofi Main Business Overview 13.2.5 Sanofi Latest Developments 13.3 Chengdu Institute of Biological Products 13.3.1 Chengdu Institute of Biological Products Company Information 13.3.2 Chengdu Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Product Portfolios and Specifications 13.3.3 Chengdu Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Sales, Revenue, Price and Gross Margin (2018-2023) 13.3.4 Chengdu Institute of Biological Products Main Business Overview 13.3.5 Chengdu Institute of Biological Products Latest Developments 13.4 Wuhan Institute of Biological Products 13.4.1 Wuhan Institute of Biological Products Company Information 13.4.2 Wuhan Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Product Portfolios and Specifications 13.4.3 Wuhan Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Sales, Revenue, Price and Gross Margin (2018-2023) 13.4.4 Wuhan Institute of Biological Products Main Business Overview 13.4.5 Wuhan Institute of Biological Products Latest Developments 13.5 Lanzhou Institute of Biological Products 13.5.1 Lanzhou Institute of Biological Products Company Information 13.5.2 Lanzhou Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Product Portfolios and Specifications 13.5.3 Lanzhou Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Sales, Revenue, Price and Gross Margin (2018-2023) 13.5.4 Lanzhou Institute of Biological Products Main Business Overview 13.5.5 Lanzhou Institute of Biological Products Latest Developments 13.6 Beijing Temple of Heaven Biological Products 13.6.1 Beijing Temple of Heaven Biological Products Company Information 13.6.2 Beijing Temple of Heaven Biological Products Live Attenuated Japanese Encephalitis Vaccine Product Portfolios and Specifications 13.6.3 Beijing Temple of Heaven Biological Products Live Attenuated Japanese Encephalitis Vaccine Sales, Revenue, Price and Gross Margin (2018-2023) 13.6.4 Beijing Temple of Heaven Biological Products Main Business Overview 13.6.5 Beijing Temple of Heaven Biological Products Latest Developments 13.7 Valneva 13.7.1 Valneva Company Information 13.7.2 Valneva Live Attenuated Japanese Encephalitis Vaccine Product Portfolios and Specifications 13.7.3 Valneva Live Attenuated Japanese Encephalitis Vaccine Sales, Revenue, Price and Gross Margin (2018-2023) 13.7.4 Valneva Main Business Overview 13.7.5 Valneva Latest Developments 13.8 Bharat Biotech 13.8.1 Bharat Biotech Company Information 13.8.2 Bharat Biotech Live Attenuated Japanese Encephalitis Vaccine Product Portfolios and Specifications 13.8.3 Bharat Biotech Live Attenuated Japanese Encephalitis Vaccine Sales, Revenue, Price and Gross Margin (2018-2023) 13.8.4 Bharat Biotech Main Business Overview 13.8.5 Bharat Biotech Latest Developments 13.9 Cheng Da Biology 13.9.1 Cheng Da Biology Company Information 13.9.2 Cheng Da Biology Live Attenuated Japanese Encephalitis Vaccine Product Portfolios and Specifications 13.9.3 Cheng Da Biology Live Attenuated Japanese Encephalitis Vaccine Sales, Revenue, Price and Gross Margin (2018-2023) 13.9.4 Cheng Da Biology Main Business Overview 13.9.5 Cheng Da Biology Latest Developments 13.10 Biocelect Pty Ltd 13.10.1 Biocelect Pty Ltd Company Information 13.10.2 Biocelect Pty Ltd Live Attenuated Japanese Encephalitis Vaccine Product Portfolios and Specifications 13.10.3 Biocelect Pty Ltd Live Attenuated Japanese Encephalitis Vaccine Sales, Revenue, Price and Gross Margin (2018-2023) 13.10.4 Biocelect Pty Ltd Main Business Overview 13.10.5 Biocelect Pty Ltd Latest Developments 13.11 Glovax Co., Ltd. 13.11.1 Glovax Co., Ltd. Company Information 13.11.2 Glovax Co., Ltd. Live Attenuated Japanese Encephalitis Vaccine Product Portfolios and Specifications 13.11.3 Glovax Co., Ltd. Live Attenuated Japanese Encephalitis Vaccine Sales, Revenue, Price and Gross Margin (2018-2023) 13.11.4 Glovax Co., Ltd. Main Business Overview 13.11.5 Glovax Co., Ltd. Latest Developments 14 Research Findings and Conclusion List of Tables/GraphsList of TablesTable 1. Live Attenuated Japanese Encephalitis Vaccine Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions) Table 2. Live Attenuated Japanese Encephalitis Vaccine Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions) Table 3. Major Players of 0.5ml Table 4. Major Players of 1ml Table 5. Major Players of 2.5ml Table 6. Global Live Attenuated Japanese Encephalitis Vaccine Sales by Type (2018-2023) & (K Units) Table 7. Global Live Attenuated Japanese Encephalitis Vaccine Sales Market Share by Type (2018-2023) Table 8. Global Live Attenuated Japanese Encephalitis Vaccine Revenue by Type (2018-2023) & ($ million) Table 9. Global Live Attenuated Japanese Encephalitis Vaccine Revenue Market Share by Type (2018-2023) Table 10. Global Live Attenuated Japanese Encephalitis Vaccine Sale Price by Type (2018-2023) & (US$/Unit) Table 11. Global Live Attenuated Japanese Encephalitis Vaccine Sales by Application (2018-2023) & (K Units) Table 12. Global Live Attenuated Japanese Encephalitis Vaccine Sales Market Share by Application (2018-2023) Table 13. Global Live Attenuated Japanese Encephalitis Vaccine Revenue by Application (2018-2023) Table 14. Global Live Attenuated Japanese Encephalitis Vaccine Revenue Market Share by Application (2018-2023) Table 15. Global Live Attenuated Japanese Encephalitis Vaccine Sale Price by Application (2018-2023) & (US$/Unit) Table 16. Global Live Attenuated Japanese Encephalitis Vaccine Sales by Company (2018-2023) & (K Units) Table 17. Global Live Attenuated Japanese Encephalitis Vaccine Sales Market Share by Company (2018-2023) Table 18. Global Live Attenuated Japanese Encephalitis Vaccine Revenue by Company (2018-2023) ($ Millions) Table 19. Global Live Attenuated Japanese Encephalitis Vaccine Revenue Market Share by Company (2018-2023) Table 20. Global Live Attenuated Japanese Encephalitis Vaccine Sale Price by Company (2018-2023) & (US$/Unit) Table 21. Key Manufacturers Live Attenuated Japanese Encephalitis Vaccine Producing Area Distribution and Sales Area Table 22. Players Live Attenuated Japanese Encephalitis Vaccine Products Offered Table 23. Live Attenuated Japanese Encephalitis Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2018-2023) Table 24. New Products and Potential Entrants Table 25. Mergers & Acquisitions, Expansion Table 26. Global Live Attenuated Japanese Encephalitis Vaccine Sales by Geographic Region (2018-2023) & (K Units) Table 27. Global Live Attenuated Japanese Encephalitis Vaccine Sales Market Share Geographic Region (2018-2023) Table 28. Global Live Attenuated Japanese Encephalitis Vaccine Revenue by Geographic Region (2018-2023) & ($ millions) Table 29. Global Live Attenuated Japanese Encephalitis Vaccine Revenue Market Share by Geographic Region (2018-2023) Table 30. Global Live Attenuated Japanese Encephalitis Vaccine Sales by Country/Region (2018-2023) & (K Units) Table 31. Global Live Attenuated Japanese Encephalitis Vaccine Sales Market Share by Country/Region (2018-2023) Table 32. Global Live Attenuated Japanese Encephalitis Vaccine Revenue by Country/Region (2018-2023) & ($ millions) Table 33. Global Live Attenuated Japanese Encephalitis Vaccine Revenue Market Share by Country/Region (2018-2023) Table 34. Americas Live Attenuated Japanese Encephalitis Vaccine Sales by Country (2018-2023) & (K Units) Table 35. Americas Live Attenuated Japanese Encephalitis Vaccine Sales Market Share by Country (2018-2023) Table 36. Americas Live Attenuated Japanese Encephalitis Vaccine Revenue by Country (2018-2023) & ($ Millions) Table 37. Americas Live Attenuated Japanese Encephalitis Vaccine Revenue Market Share by Country (2018-2023) Table 38. Americas Live Attenuated Japanese Encephalitis Vaccine Sales by Type (2018-2023) & (K Units) Table 39. Americas Live Attenuated Japanese Encephalitis Vaccine Sales by Application (2018-2023) & (K Units) Table 40. APAC Live Attenuated Japanese Encephalitis Vaccine Sales by Region (2018-2023) & (K Units) Table 41. APAC Live Attenuated Japanese Encephalitis Vaccine Sales Market Share by Region (2018-2023) Table 42. APAC Live Attenuated Japanese Encephalitis Vaccine Revenue by Region (2018-2023) & ($ Millions) Table 43. APAC Live Attenuated Japanese Encephalitis Vaccine Revenue Market Share by Region (2018-2023) Table 44. APAC Live Attenuated Japanese Encephalitis Vaccine Sales by Type (2018-2023) & (K Units) Table 45. APAC Live Attenuated Japanese Encephalitis Vaccine Sales by Application (2018-2023) & (K Units) Table 46. Europe Live Attenuated Japanese Encephalitis Vaccine Sales by Country (2018-2023) & (K Units) Table 47. Europe Live Attenuated Japanese Encephalitis Vaccine Sales Market Share by Country (2018-2023) Table 48. Europe Live Attenuated Japanese Encephalitis Vaccine Revenue by Country (2018-2023) & ($ Millions) Table 49. Europe Live Attenuated Japanese Encephalitis Vaccine Revenue Market Share by Country (2018-2023) Table 50. Europe Live Attenuated Japanese Encephalitis Vaccine Sales by Type (2018-2023) & (K Units) Table 51. Europe Live Attenuated Japanese Encephalitis Vaccine Sales by Application (2018-2023) & (K Units) Table 52. Middle East & Africa Live Attenuated Japanese Encephalitis Vaccine Sales by Country (2018-2023) & (K Units) Table 53. Middle East & Africa Live Attenuated Japanese Encephalitis Vaccine Sales Market Share by Country (2018-2023) Table 54. Middle East & Africa Live Attenuated Japanese Encephalitis Vaccine Revenue by Country (2018-2023) & ($ Millions) Table 55. Middle East & Africa Live Attenuated Japanese Encephalitis Vaccine Revenue Market Share by Country (2018-2023) Table 56. Middle East & Africa Live Attenuated Japanese Encephalitis Vaccine Sales by Type (2018-2023) & (K Units) Table 57. Middle East & Africa Live Attenuated Japanese Encephalitis Vaccine Sales by Application (2018-2023) & (K Units) Table 58. Key Market Drivers & Growth Opportunities of Live Attenuated Japanese Encephalitis Vaccine Table 59. Key Market Challenges & Risks of Live Attenuated Japanese Encephalitis Vaccine Table 60. Key Industry Trends of Live Attenuated Japanese Encephalitis Vaccine Table 61. Live Attenuated Japanese Encephalitis Vaccine Raw Material Table 62. Key Suppliers of Raw Materials Table 63. Live Attenuated Japanese Encephalitis Vaccine Distributors List Table 64. Live Attenuated Japanese Encephalitis Vaccine Customer List Table 65. Global Live Attenuated Japanese Encephalitis Vaccine Sales Forecast by Region (2024-2029) & (K Units) Table 66. Global Live Attenuated Japanese Encephalitis Vaccine Revenue Forecast by Region (2024-2029) & ($ millions) Table 67. Americas Live Attenuated Japanese Encephalitis Vaccine Sales Forecast by Country (2024-2029) & (K Units) Table 68. Americas Live Attenuated Japanese Encephalitis Vaccine Revenue Forecast by Country (2024-2029) & ($ millions) Table 69. APAC Live Attenuated Japanese Encephalitis Vaccine Sales Forecast by Region (2024-2029) & (K Units) Table 70. APAC Live Attenuated Japanese Encephalitis Vaccine Revenue Forecast by Region (2024-2029) & ($ millions) Table 71. Europe Live Attenuated Japanese Encephalitis Vaccine Sales Forecast by Country (2024-2029) & (K Units) Table 72. Europe Live Attenuated Japanese Encephalitis Vaccine Revenue Forecast by Country (2024-2029) & ($ millions) Table 73. Middle East & Africa Live Attenuated Japanese Encephalitis Vaccine Sales Forecast by Country (2024-2029) & (K Units) Table 74. Middle East & Africa Live Attenuated Japanese Encephalitis Vaccine Revenue Forecast by Country (2024-2029) & ($ millions) Table 75. Global Live Attenuated Japanese Encephalitis Vaccine Sales Forecast by Type (2024-2029) & (K Units) Table 76. Global Live Attenuated Japanese Encephalitis Vaccine Revenue Forecast by Type (2024-2029) & ($ Millions) Table 77. Global Live Attenuated Japanese Encephalitis Vaccine Sales Forecast by Application (2024-2029) & (K Units) Table 78. Global Live Attenuated Japanese Encephalitis Vaccine Revenue Forecast by Application (2024-2029) & ($ Millions) Table 79. Novartis Basic Information, Live Attenuated Japanese Encephalitis Vaccine Manufacturing Base, Sales Area and Its Competitors Table 80. Novartis Live Attenuated Japanese Encephalitis Vaccine Product Portfolios and Specifications Table 81. Novartis Live Attenuated Japanese Encephalitis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 82. Novartis Main Business Table 83. Novartis Latest Developments Table 84. Sanofi Basic Information, Live Attenuated Japanese Encephalitis Vaccine Manufacturing Base, Sales Area and Its Competitors Table 85. Sanofi Live Attenuated Japanese Encephalitis Vaccine Product Portfolios and Specifications Table 86. Sanofi Live Attenuated Japanese Encephalitis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 87. Sanofi Main Business Table 88. Sanofi Latest Developments Table 89. Chengdu Institute of Biological Products Basic Information, Live Attenuated Japanese Encephalitis Vaccine Manufacturing Base, Sales Area and Its Competitors Table 90. Chengdu Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Product Portfolios and Specifications Table 91. Chengdu Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 92. Chengdu Institute of Biological Products Main Business Table 93. Chengdu Institute of Biological Products Latest Developments Table 94. Wuhan Institute of Biological Products Basic Information, Live Attenuated Japanese Encephalitis Vaccine Manufacturing Base, Sales Area and Its Competitors Table 95. Wuhan Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Product Portfolios and Specifications Table 96. Wuhan Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 97. Wuhan Institute of Biological Products Main Business Table 98. Wuhan Institute of Biological Products Latest Developments Table 99. Lanzhou Institute of Biological Products Basic Information, Live Attenuated Japanese Encephalitis Vaccine Manufacturing Base, Sales Area and Its Competitors Table 100. Lanzhou Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Product Portfolios and Specifications Table 101. Lanzhou Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 102. Lanzhou Institute of Biological Products Main Business Table 103. Lanzhou Institute of Biological Products Latest Developments Table 104. Beijing Temple of Heaven Biological Products Basic Information, Live Attenuated Japanese Encephalitis Vaccine Manufacturing Base, Sales Area and Its Competitors Table 105. Beijing Temple of Heaven Biological Products Live Attenuated Japanese Encephalitis Vaccine Product Portfolios and Specifications Table 106. Beijing Temple of Heaven Biological Products Live Attenuated Japanese Encephalitis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 107. Beijing Temple of Heaven Biological Products Main Business Table 108. Beijing Temple of Heaven Biological Products Latest Developments Table 109. Valneva Basic Information, Live Attenuated Japanese Encephalitis Vaccine Manufacturing Base, Sales Area and Its Competitors Table 110. Valneva Live Attenuated Japanese Encephalitis Vaccine Product Portfolios and Specifications Table 111. Valneva Live Attenuated Japanese Encephalitis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 112. Valneva Main Business Table 113. Valneva Latest Developments Table 114. Bharat Biotech Basic Information, Live Attenuated Japanese Encephalitis Vaccine Manufacturing Base, Sales Area and Its Competitors Table 115. Bharat Biotech Live Attenuated Japanese Encephalitis Vaccine Product Portfolios and Specifications Table 116. Bharat Biotech Live Attenuated Japanese Encephalitis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 117. Bharat Biotech Main Business Table 118. Bharat Biotech Latest Developments Table 119. Cheng Da Biology Basic Information, Live Attenuated Japanese Encephalitis Vaccine Manufacturing Base, Sales Area and Its Competitors Table 120. Cheng Da Biology Live Attenuated Japanese Encephalitis Vaccine Product Portfolios and Specifications Table 121. Cheng Da Biology Live Attenuated Japanese Encephalitis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 122. Cheng Da Biology Main Business Table 123. Cheng Da Biology Latest Developments Table 124. Biocelect Pty Ltd Basic Information, Live Attenuated Japanese Encephalitis Vaccine Manufacturing Base, Sales Area and Its Competitors Table 125. Biocelect Pty Ltd Live Attenuated Japanese Encephalitis Vaccine Product Portfolios and Specifications Table 126. Biocelect Pty Ltd Live Attenuated Japanese Encephalitis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 127. Biocelect Pty Ltd Main Business Table 128. Biocelect Pty Ltd Latest Developments Table 129. Glovax Co., Ltd. Basic Information, Live Attenuated Japanese Encephalitis Vaccine Manufacturing Base, Sales Area and Its Competitors Table 130. Glovax Co., Ltd. Live Attenuated Japanese Encephalitis Vaccine Product Portfolios and Specifications Table 131. Glovax Co., Ltd. Live Attenuated Japanese Encephalitis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 132. Glovax Co., Ltd. Main Business Table 133. Glovax Co., Ltd. Latest Developments List of Figures Figure 1. Picture of Live Attenuated Japanese Encephalitis Vaccine Figure 2. Live Attenuated Japanese Encephalitis Vaccine Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Live Attenuated Japanese Encephalitis Vaccine Sales Growth Rate 2018-2029 (K Units) Figure 7. Global Live Attenuated Japanese Encephalitis Vaccine Revenue Growth Rate 2018-2029 ($ Millions) Figure 8. Live Attenuated Japanese Encephalitis Vaccine Sales by Region (2018, 2022 & 2029) & ($ Millions) Figure 9. Product Picture of 0.5ml Figure 10. Product Picture of 1ml Figure 11. Product Picture of 2.5ml Figure 12. Global Live Attenuated Japanese Encephalitis Vaccine Sales Market Share by Type in 2022 Figure 13. Global Live Attenuated Japanese Encephalitis Vaccine Revenue Market Share by Type (2018-2023) Figure 14. Live Attenuated Japanese Encephalitis Vaccine Consumed in Hospital Figure 15. Global Live Attenuated Japanese Encephalitis Vaccine Market: Hospital (2018-2023) & (K Units) Figure 16. Live Attenuated Japanese Encephalitis Vaccine Consumed in Clinic Figure 17. Global Live Attenuated Japanese Encephalitis Vaccine Market: Clinic (2018-2023) & (K Units) Figure 18. Global Live Attenuated Japanese Encephalitis Vaccine Sales Market Share by Application (2022) Figure 19. Global Live Attenuated Japanese Encephalitis Vaccine Revenue Market Share by Application in 2022 Figure 20. Live Attenuated Japanese Encephalitis Vaccine Sales Market by Company in 2022 (K Units) Figure 21. Global Live Attenuated Japanese Encephalitis Vaccine Sales Market Share by Company in 2022 Figure 22. Live Attenuated Japanese Encephalitis Vaccine Revenue Market by Company in 2022 ($ Million) Figure 23. Global Live Attenuated Japanese Encephalitis Vaccine Revenue Market Share by Company in 2022 Figure 24. Global Live Attenuated Japanese Encephalitis Vaccine Sales Market Share by Geographic Region (2018-2023) Figure 25. Global Live Attenuated Japanese Encephalitis Vaccine Revenue Market Share by Geographic Region in 2022 Figure 26. Americas Live Attenuated Japanese Encephalitis Vaccine Sales 2018-2023 (K Units) Figure 27. Americas Live Attenuated Japanese Encephalitis Vaccine Revenue 2018-2023 ($ Millions) Figure 28. APAC Live Attenuated Japanese Encephalitis Vaccine Sales 2018-2023 (K Units) Figure 29. APAC Live Attenuated Japanese Encephalitis Vaccine Revenue 2018-2023 ($ Millions) Figure 30. Europe Live Attenuated Japanese Encephalitis Vaccine Sales 2018-2023 (K Units) Figure 31. Europe Live Attenuated Japanese Encephalitis Vaccine Revenue 2018-2023 ($ Millions) Figure 32. Middle East & Africa Live Attenuated Japanese Encephalitis Vaccine Sales 2018-2023 (K Units) Figure 33. Middle East & Africa Live Attenuated Japanese Encephalitis Vaccine Revenue 2018-2023 ($ Millions) Figure 34. Americas Live Attenuated Japanese Encephalitis Vaccine Sales Market Share by Country in 2022 Figure 35. Americas Live Attenuated Japanese Encephalitis Vaccine Revenue Market Share by Country in 2022 Figure 36. Americas Live Attenuated Japanese Encephalitis Vaccine Sales Market Share by Type (2018-2023) Figure 37. Americas Live Attenuated Japanese Encephalitis Vaccine Sales Market Share by Application (2018-2023) Figure 38. United States Live Attenuated Japanese Encephalitis Vaccine Revenue Growth 2018-2023 ($ Millions) Figure 39. Canada Live Attenuated Japanese Encephalitis Vaccine Revenue Growth 2018-2023 ($ Millions) Figure 40. Mexico Live Attenuated Japanese Encephalitis Vaccine Revenue Growth 2018-2023 ($ Millions) Figure 41. Brazil Live Attenuated Japanese Encephalitis Vaccine Revenue Growth 2018-2023 ($ Millions) Figure 42. APAC Live Attenuated Japanese Encephalitis Vaccine Sales Market Share by Region in 2022 Figure 43. APAC Live Attenuated Japanese Encephalitis Vaccine Revenue Market Share by Regions in 2022 Figure 44. APAC Live Attenuated Japanese Encephalitis Vaccine Sales Market Share by Type (2018-2023) Figure 45. APAC Live Attenuated Japanese Encephalitis Vaccine Sales Market Share by Application (2018-2023) Figure 46. China Live Attenuated Japanese Encephalitis Vaccine Revenue Growth 2018-2023 ($ Millions) Figure 47. Japan Live Attenuated Japanese Encephalitis Vaccine Revenue Growth 2018-2023 ($ Millions) Figure 48. South Korea Live Attenuated Japanese Encephalitis Vaccine Revenue Growth 2018-2023 ($ Millions) Figure 49. Southeast Asia Live Attenuated Japanese Encephalitis Vaccine Revenue Growth 2018-2023 ($ Millions) Figure 50. India Live Attenuated Japanese Encephalitis Vaccine Revenue Growth 2018-2023 ($ Millions) Figure 51. Australia Live Attenuated Japanese Encephalitis Vaccine Revenue Growth 2018-2023 ($ Millions) Figure 52. China Taiwan Live Attenuated Japanese Encephalitis Vaccine Revenue Growth 2018-2023 ($ Millions) Figure 53. Europe Live Attenuated Japanese Encephalitis Vaccine Sales Market Share by Country in 2022 Figure 54. Europe Live Attenuated Japanese Encephalitis Vaccine Revenue Market Share by Country in 2022 Figure 55. Europe Live Attenuated Japanese Encephalitis Vaccine Sales Market Share by Type (2018-2023) Figure 56. Europe Live Attenuated Japanese Encephalitis Vaccine Sales Market Share by Application (2018-2023) Figure 57. Germany Live Attenuated Japanese Encephalitis Vaccine Revenue Growth 2018-2023 ($ Millions) Figure 58. France Live Attenuated Japanese Encephalitis Vaccine Revenue Growth 2018-2023 ($ Millions) Figure 59. UK Live Attenuated Japanese Encephalitis Vaccine Revenue Growth 2018-2023 ($ Millions) Figure 60. Italy Live Attenuated Japanese Encephalitis Vaccine Revenue Growth 2018-2023 ($ Millions) Figure 61. Russia Live Attenuated Japanese Encephalitis Vaccine Revenue Growth 2018-2023 ($ Millions) Figure 62. Middle East & Africa Live Attenuated Japanese Encephalitis Vaccine Sales Market Share by Country in 2022 Figure 63. Middle East & Africa Live Attenuated Japanese Encephalitis Vaccine Revenue Market Share by Country in 2022 Figure 64. Middle East & Africa Live Attenuated Japanese Encephalitis Vaccine Sales Market Share by Type (2018-2023) Figure 65. Middle East & Africa Live Attenuated Japanese Encephalitis Vaccine Sales Market Share by Application (2018-2023) Figure 66. Egypt Live Attenuated Japanese Encephalitis Vaccine Revenue Growth 2018-2023 ($ Millions) Figure 67. South Africa Live Attenuated Japanese Encephalitis Vaccine Revenue Growth 2018-2023 ($ Millions) Figure 68. Israel Live Attenuated Japanese Encephalitis Vaccine Revenue Growth 2018-2023 ($ Millions) Figure 69. Turkey Live Attenuated Japanese Encephalitis Vaccine Revenue Growth 2018-2023 ($ Millions) Figure 70. GCC Country Live Attenuated Japanese Encephalitis Vaccine Revenue Growth 2018-2023 ($ Millions) Figure 71. Manufacturing Cost Structure Analysis of Live Attenuated Japanese Encephalitis Vaccine in 2022 Figure 72. Manufacturing Process Analysis of Live Attenuated Japanese Encephalitis Vaccine Figure 73. Industry Chain Structure of Live Attenuated Japanese Encephalitis Vaccine Figure 74. Channels of Distribution Figure 75. Global Live Attenuated Japanese Encephalitis Vaccine Sales Market Forecast by Region (2024-2029) Figure 76. Global Live Attenuated Japanese Encephalitis Vaccine Revenue Market Share Forecast by Region (2024-2029) Figure 77. Global Live Attenuated Japanese Encephalitis Vaccine Sales Market Share Forecast by Type (2024-2029) Figure 78. Global Live Attenuated Japanese Encephalitis Vaccine Revenue Market Share Forecast by Type (2024-2029) Figure 79. Global Live Attenuated Japanese Encephalitis Vaccine Sales Market Share Forecast by Application (2024-2029) Figure 80. Global Live Attenuated Japanese Encephalitis Vaccine Revenue Market Share Forecast by Application (2024-2029)
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医薬）の最新刊レポート
LP Information社の医薬品・ヘルスケア分野での最新刊レポート
本レポートと同じKEY WORD（vaccine）の最新刊レポート
よくあるご質問LP Information社はどのような調査会社ですか?LP Informationは通信、エネルギー、医薬をはじめとする広範な市場の調査とレポート出版を行っている調査会社です。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/12/20 10:28 158.95 円 165.20 円 201.28 円 |
